{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-066130","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.217351+00:00","generated_at":"2026-05-31T11:49:31.687712+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Hoth Therapeutics shareholders re-elect board, ratify auditor, approve equity plan increase","bullets":["All five incumbent directors re-elected; vote totals ranged from 637,415 to 700,399 for each.","Ratification of WithumSmith+Brown as auditor passed with 1,763,403 votes for (79.1% of votes cast).","Amendment to 2022 Omnibus Equity Plan approved to increase reserved shares from 591,317 to 1,091,317.","Quorum of 2,230,078 shares represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-066130","json":"https://secwatch.observer/filing/0001213900-24-066130.json","markdown":"https://secwatch.observer/filing/0001213900-24-066130.md","text":"https://secwatch.observer/filing/0001213900-24-066130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024066130/0001213900-24-066130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390024066130/ea0210818-8k_hoththera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:49:31.687712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}